Skip to main content

Table 1 Correlation of COL7A1-UCN2 expression with LC clinical characteristics

From: Identification of novel enriched recurrent chimeric COL7A1-UCN2 in human laryngeal cancer samples using deep sequencing

Characteristics

Cases (%)

COL7A1-UCN2 mRNA expression

 

mRNA positive (+)

mRNA negative (−)

p

N, %

N, %

Age (years)

0.685

  ≥ 60

15 (65.2)

9 (39.1)

6 (26.1)

 

  < 60

8 (34.8)

4 (17.4)

4 (17.4)

 

Gender

1.000

 Male

20 (87.0)

11 (47.8)

9 (39.1)

 

 Female

3 (13.0)

2 (8.7)

1 (4.3)

 

Tumor stage

0.221

 I─II

8 (34.8)

3 (13.0)

5 (21.7)

 

 III─IV

15 (65.2)

10 (43.5)

5 (21.7)

 

Differentiation

1.000

 Well

4 (17.4)

2 (8.7)

2 (8.7)

 

 Moderate

16 (69.6)

9 (39.1)

7 (30.4)

 

 Poor

3 (13.0)

2 (8.7)

1 (4.3)

 

LNM

0.685

 N0

10 (43.5)

5 (15.6)

5 (15.6)

 

 N+

13 (56.5)

8 (34.8)

5 (15.6)

 

Treatment

0.685

 S only

8 (34.8)

4 (17.4)

4 (17.4)

 

 S + C/X

15 (65.2)

9 (39.1)

6 (26.1)

 

Smoking

0.435

 Ever

22 (95.7)

13 (56.5)

9 (39.1)

 

 Never

1 (4.3)

0 (0.00)

1 (4.3)

 

Alcohol

1.000

 Ever

21 (91.3)

12 (37.5)

9 (39.1)

 

 Never

2 (8.7)

1 (4.3)

1 (4.3)

 
  1. LNM lymph node metastasis, + positive, C chemotherapy, X radiation, S surgery